Insulet PODD has outperformed the market over the past 15 years by 10.12% on an annualized basis producing an average annual return of 21.15%. Currently, Insulet has a market capitalization of $18 ...
Just shy of two years after a C-suite reorganization at Insulet, Mark Field has left his position as the inaugural chief technology officer at the Acton medical device manufacturer. Field ...
Insulet (PODD) Corporation shared new Omnipod 5 clinical data from its RADIANT study. Results from this multinational randomized controlled trial were presented at the 18th International ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback